Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2007
04/04/2007CN1307976C Thorax comforting drop pills for treating cardiopathy and preparation method thereof
04/03/2007US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
04/03/2007US7199244 Cyclic amine derivatives and methods of use
04/03/2007US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents
04/03/2007US7199154 Rheumatic diseases, influenza, common cold, pain, dysmenorrhea, headache, toothache, sprains and strains, neuralgia, synovitis,arthritis, osteoarthritis, gout, bursitis, burns, injuries, and inflammation; cardiovascular disorders, anticoagulants
04/03/2007US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient
04/03/2007US7199150 Amino alcohol compounds
04/03/2007US7199147 Rho kinase inhibitors
04/03/2007US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
04/03/2007US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
04/03/2007US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
04/03/2007US7199136 Antiinflammatory agents, neutrophil elastase inhibitors; chronic obstructive pulmonary diseases
04/03/2007US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents
04/03/2007US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
04/03/2007US7199127 (2-chloropurin-9-yl)-tetrahydrothiophene-3,4-diols; anticarcinogenic agents selective to A3 adenosine receptors; breast cancer
04/03/2007US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators
04/03/2007US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation
04/03/2007US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis
04/03/2007US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
04/03/2007US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
04/03/2007US7198910 Nucleic acid encoding melanin-concentrating hormone receptor
04/03/2007US7198254 System for producing micro-cluster liquids
04/03/2007CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
04/03/2007CA2385890C Controlled release compositions comprising nimesulide
04/03/2007CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
04/03/2007CA2289570C 9-azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ach receptors
04/03/2007CA2186601C New combination of a .beta.-receptor blocker and a local anaesthetic
04/03/2007CA2181006C N,n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
04/03/2007CA2177578C Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
04/03/2007CA2176510C Method for preparing concentrated biologically active silicon compounds
03/2007
03/29/2007WO2007034958A1 Anti-angiogenic composition comprising grain-derived component as active ingredient
03/29/2007WO2007034927A1 Medicine, food and drink or feed containing sphingomyelin
03/29/2007WO2007034736A1 Adhesive skin patch
03/29/2007WO2007034277A1 Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
03/29/2007WO2007005174A3 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists
03/29/2007WO2007001932A3 Substituted isothiazolones as inhibitors of cytosolic phospholipase a2
03/29/2007WO2006131737A3 Method and composition for treating inflammatory disorders
03/29/2007WO2006124731A3 Compounds and compositions as protein kinase inhibitors
03/29/2007WO2006122250A3 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
03/29/2007WO2006110883A3 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
03/29/2007US20070072875 Anti-inflammatory compositions and methods of use
03/29/2007US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/29/2007US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/29/2007US20070072818 Endothelial growth factors; antiischemic agents; neovascularization
03/29/2007US20070071824 Treatment of mucositis using N-acetylcysteine
03/29/2007US20070071752 Sphingosine kinase enzyme
03/29/2007US20070071688 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
03/29/2007US20070070213 System for image analysis in a network that is structured with multiple layers and differentially weighted neurons
03/29/2007US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
03/29/2007CA2623304A1 Medicine, food and drink or feed containing sphingomyelin
03/28/2007EP1767641A1 Antigenic neisserial peptides
03/28/2007EP1767634A1 Novel galectin 8 modification protein and use thereof
03/28/2007EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor
03/28/2007EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor
03/28/2007EP1767219A2 Stable injectable diclofenac compositions
03/28/2007EP1767218A1 Antiinflammatory and analgesic preparation for external use
03/28/2007EP1767199A2 Methods and compositions for treatment of cancer pain
03/28/2007EP1767198A1 Regulator of physiological function of ghrelin and use thereof
03/28/2007EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use
03/28/2007EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds
03/28/2007EP1765775A1 Indoles useful in the treatment of inflammation
03/28/2007EP1765761A1 Novel analogs of 3-o-acetyl-11-keto-beta-boswellic acid
03/28/2007EP1765384A1 Method of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants
03/28/2007EP1765353A1 Solid orally ingestible formulations of tetrodotoxin
03/28/2007EP1765336A2 Angiogenesis inhibitors
03/28/2007EP1765314A1 Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
03/28/2007EP1228071B1 Pharmaceutically active isoindoline derivatives
03/28/2007EP1152760B1 Use of 4-amino pyridine for treatment of peripheral neuropathies
03/28/2007EP1059089B1 Preventives/remedies for inflammatory intestinal disease
03/28/2007CN1938326A Novel analgesic compounds, extracts containing same and methods of preparation
03/28/2007CN1938323A Silinane compounds as cysteine protease inhibitors
03/28/2007CN1938302A 激酶抑制剂 Kinase inhibitors
03/28/2007CN1938300A Oxadiazolone derivatives as PPAR delta agonists
03/28/2007CN1938276A Crystalline pyrazoles
03/28/2007CN1938045A Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
03/28/2007CN1938027A 阿片样物质递送系统 Opioid delivery system
03/28/2007CN1938016A Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
03/28/2007CN1935758A Process for producing 2-methyl-4,5-dichloro benzo trifluoride
03/28/2007CN1935260A Human antibodies that bind human tnfalpha
03/28/2007CN1935242A Chinese medicine composition, and its preparing method and quality control method
03/28/2007CN1935240A Quality control method for Chinese medicine composition preparation for treating children's cold
03/28/2007CN1935239A Chinese medicine for treating closed damage and pain
03/28/2007CN1935238A Solution for activating meridians to stop pain
03/28/2007CN1935237A Emplastrum for injury, bone, flatulence relieving and inflammation and its use
03/28/2007CN1935223A Chinese medicine composition, and its preparing method and quality control method
03/28/2007CN1935222A Medicinal liquor for treating traumatic injury
03/28/2007CN1935220A Medicinal liquor for treating traumatic injury
03/28/2007CN1935219A Medicinal liquor for removing gall
03/28/2007CN1935218A Medicinal liquor for removing gall
03/28/2007CN1935214A Joint pain pill
03/28/2007CN1935210A Medicinal liquor for treating malignant boil
03/28/2007CN1935203A Radix aconiti agrestis extract and its preparing method
03/28/2007CN1935202A Monkshood extract and its preparing method
03/28/2007CN1935200A Kusnezoff aconite leaf extract and its preparing method
03/28/2007CN1935192A Chinese medicine composition, and its preparing method and quality control method
03/28/2007CN1935190A Medicinal liquor for treating traumatic injury
03/28/2007CN1935189A Medicinal liquor for removing gall
03/28/2007CN1935177A Animal medicament with nourishing kidney and strenthening muscles, eliminating rheumatism and its preparing method
03/28/2007CN1935175A Medicinal liquor for removing gall
03/28/2007CN1935158A Pediatric paracetamol artifical low-bezoar and chlorphenzmine maleategel preparation and its preparing method